UNSPSC 51162311: Acetaminophen/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162311 Acetaminophen/phenylephrine is a Commodity code that in recent state and local procurement activity encompasses broader pharmaceutical procurement—specifically generic pharmaceuticals, over-the-counter products, and related medical supplies purchased for public health and emergency response purposes. The solicitations tagged to this code show state and local governments buying naloxone, drug deactivation systems, and multi-source generic pharmaceuticals through competitive bidding and cooperative purchasing arrangements rather than acetaminophen/phenylephrine products specifically. Issuing bodies include county health departments and state-led multistate cooperative purchasing alliances serving participating jurisdictions across multiple states; Seminole County, Florida and the Minnesota Department of Administration's Office of State Procurement (administering the Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP) are the repeat buyers in the recent record.

Recent opportunities span Florida and Minnesota with multistate reach through cooperative vehicles. Seminole County, Florida issued IFB 60459723LAS in June 2026 (response due July 26, 2023—note date inconsistency in source) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, electronic bidding through the county e-Procurement Portal, and a two-year initial term with one-year renewal option. The Minnesota Department of Administration issued an RFP through MMCAP (S1070000015802) in January 2026 (responses due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with pricing weighted at 75 percent and contract effectiveness July 1, 2026. Both procurements require vendors to meet federal compliance standards (FDA, cGMP, DSCSA for MMCAP; FEMA and Clean Air Act for Seminole County) and maintain specified insurance coverage.